Replies to post #173280 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Prurisol: 50 mil upfront, 300 mil benchmarks = $300 million over 2 years x 2.5 / 170 mil shares yields minimum ~$5.5. Parabolic increase plus advancing pipeline should double that, easily.

Brilacidin: 50 mil upfront, 900 mil benchmarks over 2 years x 2.5 / 170 mil shares yields almost triple that of Prurisol.

All the above assumes licenses, and not partnerships with profit sharing.

Also, as previously posted, the low royalty number for Brilacidin is due to the IT including a royalty structure for its inventors and previous owners.